These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22285953)

  • 41. A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
    Sookoian S; Castaño G; García SI; Viudez P; González C; Pirola CJ
    Am J Gastroenterol; 2005 Mar; 100(3):636-42. PubMed ID: 15743363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Homocysteine deteriorates intrahepatic derangement and portal-systemic collaterals in cirrhotic rats.
    Tung HC; Hsu SJ; Tsai MH; Lin TY; Hsin IF; Huo TI; Lee FY; Huang HC; Ho HL; Lin HC; Lee SD
    Clin Sci (Lond); 2017 Jan; 131(1):69-86. PubMed ID: 27803296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of constitutive nitric oxide synthase in the portal-systemic collaterals of portal hypertensive rats.
    Chang CC; Huang HC; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Lee SD
    J Chin Med Assoc; 2005 Jun; 68(6):245-9. PubMed ID: 15984816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurement of collateral circulation blood flow in anesthetized portal hypertensive rats.
    Oberti F; Maïga MY; Veal N; Fort J; Kaassis M; Moal F; Villemin E; Aubé C; Pilette C; Rifflet H; Trouvé R; Rousselet MC; Calès P
    Gastroenterol Clin Biol; 1998; 22(8-9):697-704. PubMed ID: 9823558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of vasopressin on portal-systemic collaterals of cirrhotic rats.
    Chan CC; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Huang HC; Lee SD
    Scand J Gastroenterol; 2005 Jan; 40(1):83-9. PubMed ID: 15841719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats.
    Hsu SJ; Lee FY; Wang SS; Hsin IF; Lin TY; Huang HC; Chang CC; Chuang CL; Ho HL; Lin HC; Lee SD
    Hepatology; 2015 May; 61(5):1672-84. PubMed ID: 25557829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of proton pump inhibitor on hepatic vascular responsiveness and hemodynamics in cirrhotic rats.
    Hsin IF; Hsu SJ; Chuang CL; Huo TI; Huang HC; Lee FY; Ho HL; Chang SY; Lee SD
    J Chin Med Assoc; 2018 Jul; 81(7):585-592. PubMed ID: 29780000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cirrhosis serum induces a nitric oxide-associated vascular hyporeactivity of aortic segments from healthy rats in vitro.
    Schmandra TC; Folz IC; Kimpel M; Fleming I; Holzer K; Hanisch EW
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):957-62. PubMed ID: 11507362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes.
    Hsin IF; Huang HC; Chang CC; Hsu SJ; Lee FY; Huo TI; Chuang CL; Hou MC; Lee SD
    Clin Sci (Lond); 2018 Nov; 132(22):2391-2405. PubMed ID: 30348829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats.
    Huang HC; Tsai MH; Chang CC; Pun CK; Huang YH; Hou MC; Lee FY; Hsu SJ
    Clin Sci (Lond); 2021 Dec; 135(24):2709-2728. PubMed ID: 34870313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic inhibition of nitric oxide increases the collateral vascular responsiveness to vasopressin in portal hypertensive rats.
    Huang HC; Wang SS; Chan CC; Lee FY; Chang FY; Lin HC; Hou MC; Tai CC; Lai IN; Lee SD
    J Hepatol; 2004 Feb; 40(2):234-8. PubMed ID: 14739093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
    Tsai MH; Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
    Gastroenterology; 2003 Nov; 125(5):1452-61. PubMed ID: 14598261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats.
    Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D
    J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition.
    Verhagen AM; Hohbach J; Joles JA; Braam B; Boer P; Koomans HA; Gröne H
    Eur J Pharmacol; 2000 Jul; 400(2-3):239-47. PubMed ID: 10988340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular nitric oxide production during the development of two experimental models of portal hypertension.
    Gadano AC; Sogni P; Heller J; Moreau R; Bories PN; Lebrec D
    J Hepatol; 1999 May; 30(5):896-903. PubMed ID: 10365818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronological changes in renal vascular reactivity in portal hypertensive rats.
    Chuang CL; Huang HC; Chang CC; Lee FY; Wu JC; Lee SD
    Eur J Clin Invest; 2013 Mar; 43(3):267-76. PubMed ID: 23293840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.
    Mejias M; Garcia-Pras E; Tiani C; Miquel R; Bosch J; Fernandez M
    Hepatology; 2009 Apr; 49(4):1245-56. PubMed ID: 19137587
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Asymmetric dimethylarginine (ADMA) determines the improvement of hepatic endothelial dysfunction by vitamin E in cirrhotic rats.
    Yang YY; Lee TY; Huang YT; Chan CC; Yeh YC; Lee FY; Lee SD; Lin HC
    Liver Int; 2012 Jan; 32(1):48-57. PubMed ID: 22098317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.